Health News Releases

May 25, 14:15

Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly

Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning s

May 25, 13:55

Polpharma Biologics and Tuteur Sign Licensing Agreement for a Biosimilar for Autoimmune Diseases

Polpharma Biologics, a leading biopharmaceutical company specializing in the development and manufacturing of biosimilars, today announced the signing of a landmark licensing agreement with Argentina-

May 25, 13:15

Baszucki Group Funds Oxford University Clinical Trial of Ketogenic Therapy for Early Psychosis

Baszucki Group today announced a £1.17 million grant to support a randomized controlled trial at the University of Oxford assessing the feasibility, safety, and efficacy of a ketogenic diet for patien

May 25, 13:10

Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch

Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1

May 22, 15:30

HistoSonics Receives Landmark TFDA Approval in Taiwan, Accelerating Global Expansion

HistoSonics (https://histosonics.com/), the developer of the Edison® Histotripsy System and novel histotripsy therapy platform, today announced it has received approval from the Taiwan Food and Drug A

May 22, 09:51

SINOVAC Announces Extension of Deadline to Submit Payment Instructions for Previously Declared Special Cash Dividend

Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it has extended the deadline for shareholders and nomin

May 21, 15:30

BeOne Medicines Launches One Save Changes Everything, a Global Cancer Care Awareness Campaign with Soccer Legend Tim Howard

BeOne Medicines Ltd. (https://beonemedicines.com/) (“BeOne”) (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today launched One Save Changes Everything (https://beonemedicines.com/

May 21, 08:35

Chiesi Group Announces New Chair and Vice Chair

Chiesi today announced a planned leadership change in its Board of Directors: Maria Paola Chiesi has been appointed Chair of the Board, succeeding Alessandro Chiesi, who is completing his tenure after

May 20, 16:40

InterSystems IntelliCare Becomes the First AI-Native EHR to Achieve EU Medical Device Regulation Certification

InterSystems (https://www.intersystems.com/), a creative data technology provider powering more than one billion health records globally, today announced that its electronic health record (EHR) soluti

May 20, 11:35

Samsung Bioepis Launches Ustekinumab Biosimilar, Marking Its First Product Launch in Japan

Samsung Bioepis Co., Ltd. today announced the launch of Ustekinumab BS 45 mg Syringe for S.C. Injection ‘NIPRO’, a biosimilar referencing Stelara[1] (ustekinumab), marking its first product launch in

May 20, 10:40

Prokarium Reports Positive Interim Data from Phase 1/1b PARADIGM-1 trial of ZH9 in NMIBC patients, Demonstrating Excellent Safety and Encouraging Early Efficacy

Prokarium, a clinical-stage biopharmaceutical company pioneering bacterial immunotherapies for the treatment of solid tumours, today announced safety and antitumour efficacy results from an interim re

May 19, 16:00

Organon to Present New Research on Access and Value at ISPOR 2026

Organon (NYSE: OGN), a global healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day, will present data across women’s health, biosimilars, dermatolog

May 17, 11:55

Medisca and dsm-firmenich Partner to Expand Access to Pharmaceutical-Grade Vitamin APIs for U.S. Compounding Market

Medisca, a global leader in personalized pharmaceutical medicine, has entered into a strategic partnership with dsm-firmenich, a leading ingredient manufacturer serving regulated pharmaceutical market

May 17, 11:00

Charles River Laboratories and MEDIPOST Sign Non-Exclusive MOU to Advance GMP Testing Solutions

Charles River Laboratories (CRL) and MEDIPOST Co., Ltd. (KOSDAQ 078160) have entered into a strategic, non-exclusive Memorandum of Understanding (MOU) to collaborate on GMP-compliant testing, as well

May 15, 15:30

BeOne Medicines’ BEQALZI™ (sonrotoclax) Approved by U.S. FDA as First and Only BCL2 Inhibitor for R/R Mantle Cell Lymphoma

BeOne Medicines Ltd. (https://beonemedicines.com/) (“BeOne”) (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the U.S. Food and Drug Administration (FDA) has gr

May 15, 11:30

Aster Guardians Global Nursing Award Announces Top 10 Finalists for 2026

On the occasion of International Nurses Day, Aster DM Healthcare has announced the Top 10 finalists for the fifth edition of the Aster Guardians Global Nursing Award 2026, selected from over 134,000 r

May 14, 10:10

Rigaku Accelerates Next-generation Semiconductor Metrology Development Leveraging World-Class Research Infrastructure

Rigaku Corporation, a global solution partner in X-ray analytical systems and a group company of Rigaku Holdings Corporation (headquarters: Akishima, Tokyo; CEO: Jun Kawakami; “Rigaku”), announced the

May 14, 09:30

Angelalign Technology Inc. (6699.HK) Applauds European Court Rejection of Patent Infringement Claim

Angelalign Technology Inc. (6699.HK) (“Angel”) (http://www.angelaligner.com) today said it was grateful that the Local Division Düsseldorf (Germany) of the Unified Patent Court rejected a request by A

May 13, 16:26

Oral‑B Announces The Big Rethink 2026, Launching One of Europe’s Largest Disability‑Focused Oral Health Studies

Oral B today announces The Big Rethink 2026, the next evolution of its flagship oral health inclusion programme, developed in partnership with the International Association for Disability and Oral Hea

May 13, 16:11

Takeda Announces FY2025 Full Year Results and FY2026 Outlook, Highlighted by Excellent Pipeline Progress and Solid FY2025 Results

Takeda (TOKYO:4502/NYSE:TAK (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.takeda.com%2Finvestors%2Fstock-information%2F&esheet=54533184&newsitemid=20260510786927&lan=en-US&anc

May 12, 14:30

HistoSonics Moves to Advance Additional Histotripsy Applications Announcing FDA Submission for Kidney Tumors

HistoSonics, the developer of the Edison® Histotripsy System and novel histotripsy therapy platform, today announced it has submitted a De Novo request to the U.S. Food and Drug Administration seeking

May 12, 10:15

Fujirebio Announces CE Marking of the Fully Automated Lumipulse® G pTau 217 Plasma Assay

H.U. Group Holdings Inc. and its wholly owned subsidiary Fujirebio today announced that Fujirebio Europe N.V. has obtained a CE certificate of the Lumipulse G pTau 217 Plasma assay under the Regulatio

May 11, 16:50

Pioneering feat in regenerative medicine, the BEES-HAUS cell therapy: Paracrine effect and cell engraftment, together healing urethral stricture. Its simplified version, BHES-HAUS’ results to be presented in AUA 2026

A path breaking scientific discovery, unraveling successful wound healing mechanism in urethral stricture with BEES-HAUS (https://www.ncrm.org/myth/beeshaus/) cell therapy has been reported by Indo-Ja

May 10, 15:25

BeOne Medicines Announces First Quarter 2026 Financial Results and Business Updates

BeOne Medicines Ltd. (https://beonemedicines.com/) (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced financial results and corporate updates from the first quarter of

May 10, 13:30

WHOOP Expands Health Platform with On-Demand Clinician Access and New AI Features

WHOOP (https://www.whoop.com/kr/en/?utm_source=PR&utm_medium=PR&utm_campaign=SR_A), the human performance company, today announced a new suite of health and AI-driven enhancements and feature updates

News by Region

News by Industry